The Business Research Company’s Cardiogenomics Testing Panels Market Report 2026 – Market Size, Trends, And Global Forecast 2026-2035
LONDON, GREATER LONDON, UNITED KINGDOM, July 30, 2026 /EINPresswire.com/ — “The cardiogenomics testing panels market is gaining significant traction as advancements in genetic technology and growing awareness of inherited cardiovascular conditions drive demand. This evolving field promises to revolutionize cardiovascular care through early diagnosis and personalized treatment, setting the stage for robust growth in the coming years. Let’s explore the current market size, the key factors propelling expansion, leading regions, and emerging trends shaping this important healthcare segment.
Cardiogenomics Testing Panels Market Size and Projected Growth
The cardiogenomics testing panels market has witnessed rapid expansion, with its value expected to rise from $1.55 billion in 2025 to $1.75 billion in 2026, marking a compound annual growth rate (CAGR) of 12.6%. This surge during the historical period is largely due to the increasing prevalence of cardiovascular diseases, limited access to genetic testing services, rising awareness about inherited cardiac disorders, widespread use of traditional cardiovascular diagnostic methods, and the high costs associated with early sequencing technologies. Looking ahead, the market is anticipated to grow even more dramatically, reaching $2.78 billion by 2030 at a CAGR of 12.3%. Factors such as innovations in next-generation sequencing (NGS), incorporation of artificial intelligence and bioinformatics in diagnostics, governmental support for precision medicine, greater adoption of multi-gene and whole exome panels, and a growing need for tailored cardiovascular treatments are expected to fuel this upward trajectory.
Download a free sample of the cardiogenomics testing panels market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28157&type=smp&utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Jul_PR
Understanding Cardiogenomics Testing Panels and Their Role
Cardiogenomics testing panels are specialized genetic tests that examine multiple genes simultaneously to detect inherited risks related to cardiovascular diseases like cardiomyopathies, arrhythmias, and familial hypercholesterolemia. These panels play a vital role in enabling early diagnosis, guiding personalized therapies, and assessing familial risk, which ultimately supports better clinical outcomes through targeted intervention and prevention strategies.
Inherited Cardiovascular Diseases Driving Market Demand
One of the primary forces behind the growth of the cardiogenomics testing panels market is the rising incidence of inherited cardiovascular diseases (ICDs). These genetic disorders affecting the heart and blood vessels are passed down through families. Advances in genetic testing have greatly improved the identification and diagnosis of these conditions, uncovering many cases that previously went undetected. By analyzing gene mutations responsible for hereditary cardiac issues, cardiogenomics panels aid in early diagnosis, risk stratification, and customized treatment plans. For example, a UK community health center’s Joint Strategic Needs Assessment reported that Blackpool experienced 185 deaths due to cardiovascular disease in 2023, a slight increase from 178 in 2022, highlighting the ongoing impact of these inherited disorders on public health.
View the full cardiogenomics testing panels market report:
https://www.thebusinessresearchcompany.com/report/cardiogenomics-testing-panels-global-market-report?utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Jul_PR
Rising Healthcare Spending as a Major Market Growth Factor
Increasing healthcare expenditure is another significant driver behind the expanding cardiogenomics testing panels market. Healthcare spending encompasses resources allocated by governments, private sectors, and individuals towards medical services and interventions. The growing burden of chronic diseases, which require continuous management and sophisticated diagnostic tools, has led to higher investments in health systems. This financial support facilitates advanced genetic testing and early detection of inherited cardiovascular diseases, ultimately improving patient prognoses and potentially lowering long-term healthcare costs. For instance, the UK’s Office for National Statistics reported a 5.6% nominal increase in total healthcare expenditure in 2023 compared to 2022, reflecting heightened resource allocation towards health innovations.
North America’s Leadership and Asia-Pacific’s Rapid Market Expansion
In 2025, North America held the position as the largest regional market for cardiogenomics testing panels due to its advanced healthcare infrastructure and high adoption rates of innovative diagnostics. Meanwhile, the Asia-Pacific region is forecasted to experience the fastest growth throughout the coming years, driven by increasing healthcare investments and rising awareness of genetic testing benefits. The market report covers key geographies including Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, providing a comprehensive view of global market trends and opportunities.
The 2026 edition of our market reports now delivers enhanced analytical coverage through market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, plus updated graphics and tables.
Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: marketing@tbrc.info
The Business Research Company – www.thebusinessresearchcompany.com
Follow Us On:
• LinkedIn: https://in.linkedin.com/company/the-business-research-company“
Oliver Guirdham
The Business Research Company
+44 7882 955267
info@tbrc.info
Visit us on social media:
LinkedIn
Facebook
X
Legal Disclaimer:
EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Media gallery
